INS and Hyperglycemia: Third, because stress hyperglycemia is dynamic, monitoring coupled with judicious insulin therapy may be particularly impactful in the COVID-AP interface, where glucocorticoids and vasopressors are frequently co-administered and iatrogenic glycemic excursions are common [96].